Patents Assigned to LOCL Pharma, Inc.
  • Publication number: 20220062276
    Abstract: Pharmaceutical compositions are provided which comprise effective amounts of analgesic to treat a subject, including to reduce or eliminate an adverse effect associated with the analgesic.
    Type: Application
    Filed: April 13, 2021
    Publication date: March 3, 2022
    Applicant: LOCL Pharma, Inc.
    Inventor: Paul BOSSE
  • Patent number: 10532030
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: January 14, 2020
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 10016368
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 10, 2018
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9855264
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: January 2, 2018
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9789105
    Abstract: Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: October 17, 2017
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9789104
    Abstract: Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: October 17, 2017
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9526704
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: December 27, 2016
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9498444
    Abstract: Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: November 22, 2016
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9433625
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: September 6, 2016
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9427407
    Abstract: Pharmaceutical compositions are provided which comprise effective amounts of analgesic to treat a subject, including to reduce or eliminate an adverse effect associated with the analgesic.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: August 30, 2016
    Assignee: LOCL PHARMA, INC.
    Inventor: Paul Bosse
  • Patent number: 9402813
    Abstract: Pharmaceutical compositions are provided which comprise effective amounts of analgesic to treat a subject, including to reduce or eliminate an adverse effect associated with the analgesic.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: August 2, 2016
    Assignee: LOCL PHARMA, INC.
    Inventor: Paul Bosse
  • Patent number: 9399022
    Abstract: Pharmaceutical compositions are provided which comprise effective amounts of analgesic to treat a subject, including to reduce or eliminate an adverse effect associated with the analgesic.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: July 26, 2016
    Assignee: LOCL PHARMA, INC.
    Inventor: Paul Bosse
  • Patent number: 9393207
    Abstract: Pharmaceutical compositions are provided which comprise effective amounts of analgesic to treat a subject, including to reduce or eliminate an adverse effect associated with the analgesic.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: July 19, 2016
    Assignee: LOCL PHARMA, INC.
    Inventor: Paul Bosse
  • Patent number: 9387177
    Abstract: Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: July 12, 2016
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 9226901
    Abstract: Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: January 5, 2016
    Assignee: LOCL Pharma, Inc.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku